למיקטל טבליות מסיסות/לעיסות 50 מ"ג

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

LAMOTRIGINE 50 MG

Mevcut itibaren:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC kodu:

N03AX09

Farmasötik formu:

DISPERSIBLE/CHEWABLE TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

GLAXO WELLCOME OPERATIONS LTD, UK

Terapötik grubu:

LAMOTRIGINE

Terapötik endikasyonlar:

Epilepsy: Monotherapy in adults and children over 12 years of age: 1. Simple partial seizures. 2. complex partial seizures. 3. generalised tonic clonic secondarily seizures. 4. Primary generalised tonic clonic seizures. Add-on therapy in adults and children over 2 years of age: 1. Simple partial seizures. 2. Complex partial seizures. 3. Secondarily generalised tonic clonic seizures. Adults (18 years of age and over) Lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder predominantly by preventing depressive episodes.

Yetkilendirme tarihi:

2008-11-01